Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Dan P Zandberg"'
Autor:
Robert L Ferris, Tullia C Bruno, Dan P Zandberg, Lisa A McIlvried, Andre A Martel Matos, Marci L Nilsen, Sebastien Talbot, David N Taggart, Lorin K Johnson, Nicole N Scheff, Mona M Yuan, Megan A Atherton, Fendi Obuekwe, Amin Reza Nikpoor
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background Immune checkpoint inhibitors (ICIs) are becoming the standard of care for recurrent and metastatic cancer. Opioids, the primary treatment for cancer-related pain, are immunosuppressive raising concerns about their potential to interfere wi
Externí odkaz:
https://doaj.org/article/62c796305d4944379fd6f5c90f15eae9
Autor:
Christine H Chung, Lara A Dunn, Ibrahima Soumaoro, Leonardo Nicacio, Dan P Zandberg, Douglas Adkins, Tanguy Y Seiwert, Nabil F Saba, Lova Sun, Thomas J George, William N William, Kristi Schmidt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/17b76e75d5a34466a55abfaee12a9987
Autor:
Lazar Vujanovic, Riyue Bao, Uma Duvvuri, Seungwon Kim, Robert Ferris, Aditi Kulkarni, Patricia Santos, Dan P Zandberg, Simon Chiosea, Housaiyin Li, Brian Isett, Joy Marion, Mark Kubik
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/eff971b9b63e47ca9db680664823406f
Autor:
Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/195a4377dadb4e879675192629df7c9e
Autor:
Greg M Delgoffe, Kristin DePeaux, Angen Liu, Dan P Zandberg, Ashley V Menk, Maria Velez, Daniel Normolle
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
The majority of patients with recurrent/metastatic squamous cell carcinoma of the head and neck (HNSCC) (R/M) do not benefit from anti-PD-1 therapy. Hypoxia induced immunosuppression may be a barrier to immunotherapy. Therefore, we examined the metab
Externí odkaz:
https://doaj.org/article/d0916971c66149a6a4ea79c16d0bb5d0
Autor:
Steven Borson, Yongli Shuai, Barton F. Branstetter, Marci Lee Nilsen, Marion A. Hughes, Moon Fenton, Mark Kubik, Shaum Sridharan, David A. Clump, Heath D. Skinner, Jonas T. Johnson, Simion I. Chiosea, James Ohr, Umamaheswar Duvvuri, Seungwon Kim, Katie S. Traylor, Robert Ferris, Dan P. Zandberg
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 7, Iss 3, Pp 757-765 (2022)
Abstract Objectives Data on the efficacy of including definitive local therapy to the primary site for head and neck squamous cell carcinoma (HNSCC) patients with synchronous distant metastasis are lacking. In multiple different solid tumor types, th
Externí odkaz:
https://doaj.org/article/8e063f3a91944f3ebecff1d2f616b066
Autor:
Sophie Wildsmith, Weimin Li, Song Wu, Ross Stewart, Nassim Morsli, Rajiv Raja, Qu Zhang, Jiabu Ye, Philip He, Jagdish Shetty, Alejandro Yovine, Nicholas Holoweckyj, Katia Real, Jill Walker, Magdalena Wrona, Melissa de los Reyes, Craig Barker, Jessica Whiteley, Robert Haddad, Lisa Licitra, Robert Ferris, Jérôme Fayette, Dan P. Zandberg, Lillian L. Siu, Ricard Mesía
Publikováno v:
Clinical Cancer Research. 29:2066-2074
Purpose: Biomarkers that predict response to immune checkpoint inhibitors (ICI) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) are needed. This retrospective study assessed tumor mutational burden (TMB) and outcomes in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::911eb9ff1492de58a03ea819de5f5d9a
https://doi.org/10.1158/1078-0432.ccr-22-2765
https://doi.org/10.1158/1078-0432.ccr-22-2765
Autor:
Ayana T. Ruffin, Housaiyin Li, Lazar Vujanovic, Dan P. Zandberg, Robert L. Ferris, Tullia C. Bruno
Publikováno v:
Nature Reviews Cancer. 23:173-188
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cddc3e2f89a3e0114fb6801b485bc8ec
https://doi.org/10.1038/s41568-022-00531-9
https://doi.org/10.1038/s41568-022-00531-9
Autor:
Cecelia E. Schmalbach, Thomas J. Ow, Karen Y. Choi, Miriam O'Leary, Alice Lin, Brian B. Hughley, Kevin S. Emerick, Brian Moore, Nancy Y. Lee, Dan P. Zandberg, Steven J. Wang
Publikováno v:
Head & Neck. 45:32-41
A position statement put forth by the American Head and Neck Society (AHNS) was constructed to provide evidence-based treatment recommendations for PD-1 inhibitor use in advanced cutaneous squamous cell carcinoma (cSCC). Secondarily, we sought to ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637db4b00d3d88ebe5de15cb89f5f8ec
https://doi.org/10.1002/hed.27202
https://doi.org/10.1002/hed.27202
Autor:
Ricard Mesía, Lillian L. Siu, Dan P. Zandberg, Jérôme Fayette, Robert Ferris, Lisa Licitra, Robert Haddad, Jessica Whiteley, Craig Barker, Melissa de los Reyes, Magdalena Wrona, Jill Walker, Katia Real, Nicholas Holoweckyj, Alejandro Yovine, Jagdish Shetty, Philip He, Jiabu Ye, Qu Zhang, Rajiv Raja, Nassim Morsli, Ross Stewart, Song Wu, Weimin Li, Sophie Wildsmith
FIG S2. Kaplan-Meier plot of OS in the durvalumab monotherapy, durvalumab plus tremelimumab and SoC treatment arms in the NLR ≤ 7 subgroup (A) and NLR > 7 subgroup (B) in EAGLE.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a87e88a11e0049916dc65f88972d18
https://doi.org/10.1158/1078-0432.22551834.v1
https://doi.org/10.1158/1078-0432.22551834.v1
